NuShores Biosciences LLC
NuShores Biosciences LLC, founded in 2014, is dedicated to commercializing patented bone and tissue regeneration technologies developed at the University of Arkansas at Little Rock. The company aims to improve the quality of life for individuals with severe tissue regeneration needs through innovative solutions like the NuCress™ bone scaffold technology, which is designed to promote healing in large segmental bone defects.
Industries
Nr. of Employees
small (1-50)
NuShores Biosciences LLC
1523 South Bowman St. Suite 3-H, Little Rock, Arkansas 72211
Products
Bone void filler polymeric scaffold (pre-market)
A controlled-porosity, hydrophilic polymeric bone scaffold intended to fill large segmental bone defects and support bone regeneration; designed for surgical use in cranio-maxillofacial, dental, limb, and spinal indications. Product is not FDA cleared or available for sale.
Bone void filler polymeric scaffold (pre-market)
A controlled-porosity, hydrophilic polymeric bone scaffold intended to fill large segmental bone defects and support bone regeneration; designed for surgical use in cranio-maxillofacial, dental, limb, and spinal indications. Product is not FDA cleared or available for sale.
Services
Contracted design and prototyping of automated production platforms for polymeric implantable devices, including intelligent vessels, reactors, process modeling, and integration of sensor-based control systems.
Development and implementation of quality management systems and regulatory strategies to support medical device submissions and post-market compliance; staffing and advisory support for FDA interaction and audit readiness.
Contracted design and prototyping of automated production platforms for polymeric implantable devices, including intelligent vessels, reactors, process modeling, and integration of sensor-based control systems.
Development and implementation of quality management systems and regulatory strategies to support medical device submissions and post-market compliance; staffing and advisory support for FDA interaction and audit readiness.
Expertise Areas
- Bone and tissue regeneration
- Biomaterials development for implantable scaffolds
- Preclinical animal models and translational research
- Medical device manufacturing and production scale-up
Key Technologies
- Controlled-porosity polymeric scaffolds
- Hydrophilic in situ-swelling implant design
- Bioabsorbable polyurethane polymerization
- DBM (demineralized bone matrix) and hydroxyapatite composite integration
News & Updates
NuShores Biosciences LLC will receive nearly half a million dollars to be added to their current 3-year contract awarded through the Medical Technology Enterprise Consortium (MTEC).
NuShores Biosciences LLC has been awarded a $50,000 grant from Medical Technology Enterprise Consortium to support the commercialization of their NuCress™ bone filler scaffolds.
Sam Monk, a seasoned medical device professional, will help to lead NuShores’ quality and regulatory efforts for NuCress™ bone regenerative product line.
NuShores Biosciences LLC will receive nearly half a million dollars to be added to their current 3-year contract awarded through the Medical Technology Enterprise Consortium (MTEC).
NuShores Biosciences LLC has been awarded a $50,000 grant from Medical Technology Enterprise Consortium to support the commercialization of their NuCress™ bone filler scaffolds.
Sam Monk, a seasoned medical device professional, will help to lead NuShores’ quality and regulatory efforts for NuCress™ bone regenerative product line.